Cellares: $257 Million Series D Closed To Scale Automated Cell Therapy Manufacturing
By Amit Chowdhry ● Jan 29, 2026
Cellares has raised $257 million in a Series D financing co-led by investment funds managed by BlackRock and Eclipse, bringing total capital raised to $612 million. The round brings in a slate of new investors, including accounts advised by T. Rowe Price Investment Management, Baillie Gifford, Duquesne Family Office, Intuitive Ventures, EDBI, and Gates Frontier, alongside existing backers DC Global Ventures, DFJ Growth, and Willett Advisors.